Pharmafile Logo
Pharmafocus logo
Advanced Search

erhlers

Showing 1 posts of 1 posts found.

biogen_austria_238

New head of R&D at Biogen

April 27, 2016
Research and Development Biogen, Pfizer, R&D, erhlers, michael, michael erhlers, research and development

Biogen (NASDAQ: BIIB) has announced the appointment of Dr Michael Ehlers as executive vice president, research and development. His role …

Appointment
The Gateway to Local Adoption Series

Latest content

Breast Cancer Now commits £800,000 to AI research into late breast cancer recurrence

October 28, 2026

AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over

October 27, 2026

Acumentis CEO Herspiegel steps down as Burden assumes role

October 27, 2026

Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia

October 27, 2026

Hot-tub therapy tested as potential treatment for peripheral artery disease

October 26, 2026